601 related articles for article (PubMed ID: 9811831)
1. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
[TBL] [Abstract][Full Text] [Related]
2. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
3. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
[TBL] [Abstract][Full Text] [Related]
4. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
6. [Cowden disease].
Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
[TBL] [Abstract][Full Text] [Related]
7. [PTEN: a tumor suppressor with original properties].
Roux P
Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
[TBL] [Abstract][Full Text] [Related]
8. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
10. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
[TBL] [Abstract][Full Text] [Related]
11. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
Wishart MJ; Dixon JE
Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
[TBL] [Abstract][Full Text] [Related]
12. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
Maehama T; Dixon JE
J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
[TBL] [Abstract][Full Text] [Related]
14. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
15. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.
Nelen MR; van Staveren WC; Peeters EA; Hassel MB; Gorlin RJ; Hamm H; Lindboe CF; Fryns JP; Sijmons RH; Woods DG; Mariman EC; Padberg GW; Kremer H
Hum Mol Genet; 1997 Aug; 6(8):1383-7. PubMed ID: 9259288
[TBL] [Abstract][Full Text] [Related]
18. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
Longy M
Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
[TBL] [Abstract][Full Text] [Related]
19. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
[TBL] [Abstract][Full Text] [Related]
20. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
